{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T18:21:02Z","timestamp":1759602062032,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s12094-018-1892-6","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T10:27:43Z","timestamp":1528108063000},"page":"1571-1576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Choice of antiepileptic drugs affects the outcome in cancer patients with seizures"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9289-5312","authenticated-orcid":false,"given":"B.","family":"Cacho-Diaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"San-Juan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Salmeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Boyzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5456-6999","authenticated-orcid":false,"given":"N.","family":"Lorenzana-Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"issue":"4","key":"1892_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/nop\/npv038","volume":"3","author":"CP B\u00e9nit","year":"2016","unstructured":"B\u00e9nit CP, Vecht CJ. Seizures and cancer: drug interactions of anticonvulsants with chemotherapeutic agents, tyrosine kinase inhibitors and glucocorticoids. Neuro Oncol Pract. 2016;3(4):245\u201360.","journal-title":"Neuro Oncol Pract."},{"issue":"5","key":"1892_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","volume":"6","author":"MSM Breemen van","year":"2007","unstructured":"van Breemen MSM, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007;6(5):421\u201330.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1892_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/brain\/awt345","volume":"137","author":"J Pallud","year":"2014","unstructured":"Pallud J, Audureau E, Blonski M, Sanai N, Bauchet L, Fontaine D, et al. Epileptic seizures in diffuse low-grade gliomas in adults. Brain. 2014;137(2):449\u201362.","journal-title":"Brain"},{"issue":"7","key":"1892_CR4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1468-1331.2006.01506.x","volume":"13","author":"R Soffietti","year":"2006","unstructured":"Soffietti R, Cornu P, Delattre JY, Grant R, Graus F, Grisold W, et al. EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol. 2006;13(7):674\u201381.","journal-title":"Eur J Neurol"},{"issue":"7","key":"1892_CR5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1093\/neuonc\/nov032","volume":"17","author":"JAF Koekkoek","year":"2015","unstructured":"Koekkoek JAF, Kerkhof M, Dirven L, Heimans JJ, Reijneveld JC, Taphoorn MJB. Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review. Neuro Oncol. 2015;17(7):924\u201334.","journal-title":"Neuro Oncol"},{"issue":"6","key":"1892_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/00019052-199612000-00005","volume":"9","author":"JG Villemure","year":"1996","unstructured":"Villemure JG, de Tribolet N. Epilepsy in patients with central nervous system tumors. Curr Opin Neurol. 1996;9(6):424\u20138.","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"1892_CR7","first-page":"143","volume":"21","author":"M Riva","year":"2016","unstructured":"Riva M. Epilepsy in neuro-oncology: a review. Eur J Oncol. 2016;21(3):143\u201356.","journal-title":"Eur J Oncol"},{"issue":"1","key":"1892_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0733-8619(02)00034-8","volume":"21","author":"SR Plotkin","year":"2003","unstructured":"Plotkin SR, Wen PY. Neurologic complications of cancer therapy. Neurol Clin NA. 2003;21(1):279\u2013318.","journal-title":"Neurol Clin NA"},{"issue":"2","key":"1892_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3171\/JNS\/2008\/108\/2\/0227","volume":"108","author":"EF Chang","year":"2008","unstructured":"Chang EF, Potts MB, Keles GE, Lamborn KR. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg. 2008;108(2):227\u201335.","journal-title":"J Neurosurg"},{"issue":"1","key":"1892_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0959-8049(97)00374-2","volume":"34","author":"K Lote","year":"1998","unstructured":"Lote K, Stenwig AE, Skullerud K, Hirschberg H. Original paper prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer. 1998;34(1):98\u2013102.","journal-title":"Eur J Cancer"},{"issue":"10","key":"1892_CR11","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/jnnp.47.10.1087","volume":"47","author":"JB Chalk","year":"1984","unstructured":"Chalk JB, Ridgeway K, Brophy T, Yelland JD, Eadie MJ. Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry. 1984;47(10):1087\u201390.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1892_CR12","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/clpt.1988.45","volume":"43","author":"C Neef","year":"1988","unstructured":"Neef C, de Voogd-van der Straaten I. An interaction between cytostatic and anticonvulsant drugs. Clin Pharmacol Ther. 1988;43(4):372\u20135.","journal-title":"Clin Pharmacol Ther"},{"key":"1892_CR13","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","volume":"54","author":"MJ Glantz","year":"2000","unstructured":"Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54:1886\u201393.","journal-title":"Neurology"},{"issue":"4","key":"1892_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2016.26","volume":"12","author":"G Huberfeld","year":"2016","unstructured":"Huberfeld G, Vecht CJ. Seizures and gliomas\u2014towards a single therapeutic approach. Nat Rev Neurol. 2016;12(4):204\u201316.","journal-title":"Nat Rev Neurol."},{"issue":"5 Suppl 4","key":"1892_CR15","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1212\/WNL.51.5_Suppl_4.S2","volume":"51","author":"TR Browne","year":"1998","unstructured":"Browne TR. Pharmacokinetics of antiepileptic drugs. Neurology. 1998;51(5 Suppl 4):S2\u20137.","journal-title":"Neurology"},{"key":"1892_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.clineuro.2016.05.002","volume":"146","author":"T Wegman-Ostrosky","year":"2016","unstructured":"Wegman-Ostrosky T, Reynoso-Nover\u00f3n N, Mej\u00eda-P\u00e9rez SI, S\u00e1nchez-Correa TE, Alvarez-G\u00f3mez RM, Vidal-Mill\u00e1n S, et al. Clinical prognostic factors in adults with astrocytoma: Historic cohort. Clin Neurol Neurosurg. 2016;146:116\u201322.","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"1892_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10072-006-0708-6","volume":"27","author":"M Riva","year":"2006","unstructured":"Riva M, Salmaggi A, Marchioni E, Silvani A, Tomei G, Lorusso L, et al. Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group. Neurol Sci. 2006;27(5):345\u201351.","journal-title":"Neurol Sci."},{"issue":"19","key":"1892_CR18","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1212\/WNL.0000000000003911","volume":"88","author":"H Chen","year":"2017","unstructured":"Chen H, Judkins J, Thomas C, Wu M, Khoury L, Benjamin CG, et al. Mutant IDH1 and seizures in patients with glioma. Neurology. 2017;88(19):1805\u201313.","journal-title":"Neurology."},{"issue":"7","key":"1892_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/nrc1887","volume":"6","author":"CD Scripture","year":"2006","unstructured":"Scripture CD, Figg WD. Drug interactions in cancer therapy. Nat Rev Cancer. 2006;6(7):546\u201358.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1892_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/jnnp.2006.106211","volume":"78","author":"G Singh","year":"2006","unstructured":"Singh G, Rees JH, Sander JW. Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment. J Neurol Neurosurg Psychiatry. 2006;78(4):342\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"1892_CR21","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.clinthera.2008.08.011","volume":"30","author":"KY-L Yap","year":"2008","unstructured":"Yap KY-L, Chui WK, Chan A. Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Ther. 2008;30(8):1385\u2013407.","journal-title":"Clin Ther"},{"issue":"3","key":"1892_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","volume":"72","author":"S Oberndorfer","year":"2005","unstructured":"Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W. P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol. 2005;72(3):255\u201360.","journal-title":"J Neurooncol"},{"issue":"7","key":"1892_CR23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/neuonc\/not057","volume":"15","author":"M Kerkhof","year":"2013","unstructured":"Kerkhof M, Dielemans JCM, van Breemen MS, Zwinkels H, Walchenbach R, Taphoorn MJ, et al. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Neuro Oncol. 2013;15(7):961\u20137.","journal-title":"Neuro Oncol"},{"issue":"7","key":"1892_CR24","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1200\/JCO.2015.63.6563","volume":"34","author":"C Happold","year":"2016","unstructured":"Happold C, Gorlia T, Chinot O, Gilbert MR, Nabors LB, Wick W, et al. Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma. J Clin Oncol. 2016;34(7):731\u20139.","journal-title":"J Clin Oncol"},{"key":"1892_CR25","first-page":"1186","volume":"2","author":"B Cacho-Diaz","year":"2017","unstructured":"Cacho-Diaz B, Lorenzana-Mendoza NA. Valproic acid in patients with glioma: a small review. Clin Oncol. 2017;2:1186\u20138.","journal-title":"Clin Oncol"},{"issue":"1","key":"1892_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ane.12437","volume":"133","author":"HA Gefroh-Grimes","year":"2015","unstructured":"Gefroh-Grimes HA, Gidal BE. Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokinetics. Acta Neurol Scand. 2015;133(1):4\u201316.","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"1892_CR27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1634\/theoncologist.2014-0060","volume":"19","author":"CJ Vecht","year":"2014","unstructured":"Vecht CJ, Kerkhof M, Duran-Pena A. Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist. 2014;19(7):751\u20139.","journal-title":"Oncologist"},{"issue":"4","key":"1892_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3171\/2012.10.JNS12169","volume":"118","author":"GD Guthrie","year":"2013","unstructured":"Guthrie GD, Eljamel S. Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme. J Neurosurg. 2013;118(4):859\u201365.","journal-title":"J Neurosurg"},{"issue":"15","key":"1892_CR29","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1212\/WNL.0b013e3181bbfeca","volume":"73","author":"KA Jaeckle","year":"2009","unstructured":"Jaeckle KA, Ballman K, Furth A, Buckner JC. Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma. Neurology. 2009;73(15):1207\u201313.","journal-title":"Neurology."},{"issue":"26","key":"1892_CR30","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1016\/j.lfs.2005.01.003","volume":"76","author":"AS Beutler","year":"2005","unstructured":"Beutler AS, Li S, Nicol R, Walsh MJ. Carbamazepine is an inhibitor of histone deacetylases. Life Sci. 2005;76(26):3107\u201315.","journal-title":"Life Sci"},{"key":"1892_CR31","first-page":"CD001031","volume":"11","author":"SJ Nevitt","year":"2016","unstructured":"Nevitt SJ, Tudur Smith C, Weston J, Marson AG. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev. 2016;11:CD001031.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9566","key":"1892_CR32","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","volume":"369","author":"AG Marson","year":"2007","unstructured":"Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369(9566):1000\u201315.","journal-title":"Lancet"},{"issue":"9566","key":"1892_CR33","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","volume":"369","author":"AG Marson","year":"2007","unstructured":"Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369(9566):1016\u201326.","journal-title":"Lancet"},{"issue":"1","key":"1892_CR34","doi-asserted-by":"publisher","first-page":"e0169974","DOI":"10.1371\/journal.pone.0169974","volume":"12","author":"KD Taing","year":"2017","unstructured":"Taing KD, O\u2019Brien TJ, Williams DA, French CR. Anti-epileptic drug combination efficacy in an in vitro seizure model\u2014phenytoin and valproate, lamotrigine and valproate. PLoS One. 2017;12(1):e0169974.","journal-title":"PLoS One."},{"issue":"3","key":"1892_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11060-006-9229-7","volume":"81","author":"AM Mauro","year":"2007","unstructured":"Mauro AM, Bomprezzi C, Morresi S, Provinciali L, Formica F, Iacoangeli M, et al. Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepine. J Neurooncol. 2007;81(3):279\u201385.","journal-title":"J Neurooncol"},{"issue":"1","key":"1892_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1756-9966-28-60","volume":"28","author":"M Maschio","year":"2009","unstructured":"Maschio M, Dinapoli L, Vidiri A, Pace A, Fabi A, Pompili A, et al. The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine. J Exp Clin Cancer Res. 2009;28(1):60.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1892_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.yebeh.2008.02.001","volume":"13","author":"EA Dogan","year":"2008","unstructured":"Dogan EA, Usta BE, Bilgen R, Senol Y, Aktekin B. Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy. Epilepsy Behav. 2008;13(1):156\u201361.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"1892_CR38","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s11060-011-0689-z","volume":"106","author":"M Maschio","year":"2012","unstructured":"Maschio M, Dinapoli L, Sperati F, Fabi A, Pace A, Vidiri A, et al. Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life. J Neurooncol. 2012;106(3):651\u20136.","journal-title":"J Neurooncol"},{"issue":"30","key":"1892_CR39","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1200\/JCO.2015.60.9503","volume":"33","author":"X Lin","year":"2015","unstructured":"Lin X, DeAngelis LM. Treatment of brain metastases. J Clin Oncol. 2015;33(30):3475\u201384.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1892_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/neuonc\/now190","volume":"19","author":"EK Avila","year":"2016","unstructured":"Avila EK, Chamberlain M, Schiff D, Reijneveld JC, Armstrong TS, Ruda R, et al. Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials. Neuro Oncol. 2016;19(1):12\u201321.","journal-title":"Neuro Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-018-1892-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-018-1892-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-018-1892-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T19:23:43Z","timestamp":1559589823000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-018-1892-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1892"],"URL":"https:\/\/doi.org\/10.1007\/s12094-018-1892-6","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"type":"print","value":"1699-048X"},{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2018,6,4]]},"assertion":[{"value":"23 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional ethics and scientific committee approved this research. All procedures performed in studies involving humans were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}